1. Repository of OAI
Ελληνικά   English  

Browsing by Author Bourantas, K. L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 50 to 69 of 96 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactionsBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T.24-Nov-2015-
Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromesTsiara, S. N.; Kapsali, H. D.; Panteli, K.; Christou, L.; Bourantas, K. L.24-Nov-2015-
Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patientsTerpos, E.; Mougiou, A.; Kouraklis, A.; Chatzivassili, A.; Michalis, E.; Giannakoulas, N.; Manioudaki, E.; Lazaridou, A.; Bakaloudi, V.; Protopappa, M.; Liapi, D.; Grouzi, E.; Parharidou, A.; Symeonidis, A.; Kokkini, G.; Laoutaris, N. P.; Vaipoulos, G.; Anagnostopoulos, N. I.; Christakis, J. I.; Meletis, J.; Bourantas, K. L.; Zoumbos, N. C.; Yataganas, X.; Viniou, N. A.24-Nov-2015-
Prolonged interferon-alpha-2b treatment of hairy cell leukemia patientsBourantas, K. L.; Hatzimichael, E. C.; Makis, A. C.; Kapsali, E.; Tsiara, S.; Christou, L.; Seferiadis, K.24-Nov-2015-
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaHatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T.24-Nov-2015-
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myelomaBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L.24-Nov-2015-
Quantitation of HBF gamma-chain types by HPLC in patients with myelodysplastic syndromeBourantas, K. L.; Georgiou, I.; Seferiadis, K.24-Nov-2015-
A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphomaPangalis, G. A.; Vassilakopoulos, T. P.; Michalis, E.; Roussou, P.; Vrakidou, E.; Repousis, P.; Angelopoulou, M. K.; Siakantaris, M. P.; Korantzis, J.; Symeonidis, A.; Grigorakis, V.; Stefanoudakis, E.; Stamatellou, M.; Bourantas, K. L.; Kalmantis, T.; Christopoulos, G.; Kokkinis, G.; Mihalakeas, I.; Papayiannis, A.24-Nov-2015-
Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosisTsiara, S. N.; Chaidos, A.; Bourantas, L. K.; Kapsali, H. D.; Bourantas, K. L.24-Nov-2015-
Recombinant human erythropoietin for the treatment of anemia in chronic myelogenous leukemiaBourantas, K. L.; Tsiara, S.; Makis, A.; Chaidos, A.; Christou, L.; Konstantinidou, P.; Kolios, G.; Seferiadis, K.24-Nov-2015-
Recombinant human erythropoietin for the treatment of refractory anemia in lymphoproliferative disorders: preliminary resultsTsiara, S.; Kaiafas, P.; Kapsali, E.; Christou, L.; Bourantas, K. L.24-Nov-2015-
Recombinant human erythropoietin in a triplet pregnancy: a case reportLialios, G.; Kallitsaris, A.; Bourantas, K. L.; Messinis, I. E.24-Nov-2015-
Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patientMakis, A. C.; Chaliasos, N.; Hatzimichael, E. C.; Bourantas, K. L.24-Nov-2015-
Recombinant human erythropoietin treatment of postpartum anemia. Preliminary resultsMakrydimas, G.; Lolis, D.; Lialios, G.; Tsiara, S.; Georgiou, I.; Bourantas, K. L.24-Nov-2015-
Renal abnormalities in patients with sickle cell-beta thalassemiaKatopodis, K. P.; Elisaf, M. S.; Pappas, H. A.; Theodorou, J. C.; Milionis, H. J.; Bourantas, K. L.; Siamopoulos, K. C.24-Nov-2015-
Rheumatoid arthritis and B-cell chronic lymphocytic leukemiaVoulgari, P. V.; Vartholomatos, G.; Kaiafas, P.; Bourantas, K. L.; Drosos, A. A.24-Nov-2015-
Rheumatoid arthritis in patients with hemoglobinopathiesPliakou, X. I.; Koutsouka, F. P.; Damigos, D.; Bourantas, K. L.; Briasoulis, E.; Voulgari, P. V.24-Nov-2015-
Rituximab (anti-CD20 monoclonal antibody) administration in a young patient with resistant B-prolymphocytic leukemiaVartholomatos, G.; Tsiara, S.; Christou, L.; Panteli, A.; Kaiafas, P.; Bourantas, K. L.24-Nov-2015-
Rituximab as first line treatment for MALT lymphoma of extraocular musclesBenetatos, L.; Alymara, V.; Asproudis, I.; Bourantas, K. L.24-Nov-2015-
The role of cytokines in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Bourantas, K. L.24-Nov-2015-
Showing results 50 to 69 of 96 < previous   next >